Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
BCAL Diagnostics Limited ( (AU:BDX) ) just unveiled an announcement.
BCAL Diagnostics Limited has announced a change in the interests of its director, Jayne Shaw, in the company’s securities. The change involves an acquisition of 96,722 ordinary shares through an on-market purchase, bringing her total holdings to various amounts across different accounts. This update reflects the director’s increased stake in the company, potentially signaling confidence in the company’s future prospects.
More about BCAL Diagnostics Limited
Average Trading Volume: 440,858
Technical Sentiment Signal: Buy
Current Market Cap: A$34.21M
For a thorough assessment of BDX stock, go to TipRanks’ Stock Analysis page.